11-Apr-2025
Pharma, MedTech stocks bounce back as Trump pauses tariffs
Seeking Alpha News (Wed, 9-Apr 2:26 PM ET)
Pharma, MedTech stocks bounce back as Trump pauses most tariffs
Seeking Alpha News (Wed, 9-Apr 2:26 PM ET)
Globe Newswire (Mon, 31-Mar 4:21 PM ET)
PRNewswire (Sun, 30-Mar 11:00 AM ET)
Globe Newswire (Mon, 10-Mar 9:16 AM ET)
CGS Transforms Workplace Training with Cicero, a New AI-Driven, Customizable Roleplay Platform
Globe Newswire (Mon, 10-Mar 7:00 AM ET)
PRNewswire (Sun, 9-Mar 2:00 PM ET)
Bullish On MDT? You Might Want To Consider This Credit Put Spread Expiring in 21 Days
Market Chameleon (Fri, 7-Mar 6:04 AM ET)
Medtronic announces cash dividend for fourth quarter of fiscal year 2025
PRNewswire (Thu, 6-Mar 4:30 PM ET)
PRNewswire (Mon, 24-Feb 9:00 AM ET)
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Medtronic Plc. trades on the NYSE stock market under the symbol MDT.
As of April 11, 2025, MDT stock price climbed to $82.90 with 7,260,883 million shares trading.
MDT has a beta of 0.38, meaning it tends to be less sensitive to market movements. MDT has a correlation of 0.11 to the broad based SPY ETF.
MDT has a market cap of $106.30 billion. This is considered a Large Cap stock.
Last quarter Medtronic Plc. reported $8 billion in Revenue and $1.39 earnings per share. This fell short of revenue expectation by $-38 million and exceeded earnings estimates by $.03.
In the last 3 years, MDT traded as high as $114.31 and as low as $68.84.
The top ETF exchange traded funds that MDT belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
MDT has underperformed the market in the last year with a price return of +4.3% while the SPY ETF gained +4.5%. However, in the short term, MDT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +3.6% vs -7.7% return in SPY. But in the last 2 weeks, MDT shares have been beat by the market, returning -5.4% compared to an SPY return of -3.9%.
MDT support price is $81.07 and resistance is $84.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDT shares will trade within this expected range on the day.